BCL11A and triple-negative breast carcinoma: Through binding to microRNA-4753 and microRNA-6809, circEPSTI1 upregulates expression of B cell CLL/lymphoma 11A (BCL11A), promotes the proliferation of triple-negative breast cancer cells, and inhibits their apoptosis (41).